Walmart and Care Access Plan Three Additional Clinical Trial Centers to Expand Access to Medical Research
Business Wire•27/10/2026•13:00 ET
0
Key Highlights
- ➤Three additional centers planned in Michigan, Nevada, and Texas in first half of 2027
- ➤Four initial centers opened across Texas, Georgia, and Florida
- ➤Clinical Trial Centers will support Phase 2, 3, and 4 clinical trials
- ➤Care Access operates over 200 clinical research sites worldwide
- ➤Walmart reported fiscal year 2026 revenue of $713 billion
Expert Statements
Ahmad Namvargolian, CEO and Co-Founder of Care Access
“Opening these locations is an important step in advancing our mission to make clinical research accessible to all”
Emily Aaronson, M.D., MPH, Chief Medical Officer at Walmart
“Expanding access to clinical research starts with making opportunities available in more communities”
Michael Franklin, Vice President, Community-Based Research & Innovation, Eli Lilly and Company
“Expanding access to clinical research has long been a priority for Lilly because the future of medicine depends on participation from people with a wide range of backgrounds, experiences, and health needs”
Walmart and Care Access Plan Three Additional Clinical Trial Centers to Expand Access to Medical Research
Building on four initial locations in Texas, Georgia, and Florida, planned expansion into additional communities across three states aims to bring research opportunities closer to where people live and shop.
Get started
Create a free account to read the full story.